This spreadsheet contains all of the raw unspliced, multiply-spliced, and plasma HIV RNA data for the prospective panobinostat clinical trial that was obtained or used in this manuscript (see Figure 4
IQR, interquartile range; HAART, highly active antiretroviral therapy. aHCV status was determined at enrollment. Follow-up HCV RNA testing was conducted on all women who were HCVAb+ at enrollment and